Published in Biochem J on December 01, 1994
Increased μ-Calpain Activity in Blasts of Common B-Precursor Childhood Acute Lymphoblastic Leukemia Correlates with Their Lower Susceptibility to Apoptosis. PLoS One (2015) 1.39
Calcium in red blood cells-a perilous balance. Int J Mol Sci (2013) 1.02
Cytoplasmic calcium buffers in intact human red cells. J Physiol (1997) 0.88
Exogenous normal lymph alleviates microcirculation disturbances and abnormal hemorheological properties in rats with disseminated intravascular coagulation. Braz J Med Biol Res (2013) 0.77
Clinical severity of β-thalassaemia/Hb E disease is associated with differential activities of the calpain-calpastatin proteolytic system. PLoS One (2012) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev (1991) 3.53
Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A (1993) 2.58
A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells. Exp Cell Res (1992) 1.04
Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites. Proc Natl Acad Sci U S A (1987) 1.02
Effect of Ca2+ on binding of the calpains to calpastatin. J Biol Chem (1989) 0.98
Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance. FEBS Lett (1986) 0.97
Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue. Neurobiol Aging (1990) 0.91
Regulation of activity of calcium activated neutral protease. Adv Enzyme Regul (1988) 0.90
Proteolytic modification of membrane-associated phospholipase C-beta by mu-calpain enhances its activation by G-protein beta gamma subunits in human platelets. FEBS Lett (1994) 0.89
The calpain-calpastatin system in mammalian cells: properties and possible functions. Biochimie (1992) 0.88
Calpastatins: biochemical and molecular biological studies. Biomed Biochim Acta (1991) 0.87
Molecular diversity of calpastatin in human erythroid cells. Arch Biochem Biophys (1993) 0.87
Calpain (Ca(2+)-dependent thiol protease) in erythrocytes of young and old individuals. Proc Natl Acad Sci U S A (1994) 0.86
Calpastatin has two distinct sites for interaction with calpain--effect of calpastatin fragments on the binding of calpain to membranes. Arch Biochem Biophys (1993) 0.85
Band 3 protein degradation by calpain is enhanced in erythrocytes of old people. Biochem J (1991) 0.85
A variety of calpain/calpastatin systems in mammalian erythrocytes. Biochim Biophys Acta (1993) 0.85
Membrane-mobility agent-promoted fusion of erythrocytes: fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins. Proc Natl Acad Sci U S A (1983) 0.85
Properties of erythrocyte membrane binding and autolytic activation of calcium-activated neutral protease. J Biol Chem (1989) 0.85
Proteolysis of the calcium-dependent protease inhibitor by myocardial calcium-dependent protease. Arch Biochem Biophys (1986) 0.84
Fragmentation of an endogenous inhibitor upon complex formation with high- and low-Ca2+-requiring forms of calcium-activated neutral proteases. Biochemistry (1989) 0.82
Ca2+-dependent association between a Ca2+-activated neutral proteinase (CaANP) and its specific inhibitor. FEBS Lett (1981) 0.82
The binding of large calpastatin to biologic membranes is mediated in part by interaction of an amino terminal region with acidic phospholipids. Biochim Biophys Acta (1989) 0.82
Different susceptibility of red cell membrane proteins to calpain degradation. Arch Biochem Biophys (1992) 0.81
Immunolocalization of the calpains and calpastatin in human and bovine platelets. Biomed Biochim Acta (1991) 0.80
Molecular diversity of calpastatin in mammalian organs. Biochem Biophys Res Commun (1984) 0.80
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell (1990) 8.30
Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide. Biochem Biophys Res Commun (1969) 3.55
The glutathione status of cells. Int Rev Cytol (1978) 3.24
Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J Biol Chem (1994) 3.22
Math5 is required for retinal ganglion cell and optic nerve formation. Development (2001) 3.07
An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell (1990) 3.02
Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing. Genes Dev (1994) 2.99
Math5 encodes a murine basic helix-loop-helix transcription factor expressed during early stages of retinal neurogenesis. Development (1998) 2.38
Seven polymorphic loci mapping to human chromosomal region 11q22-qter. Genomics (1988) 2.23
Lest I forget thee, glutathione. Nature (1969) 1.95
Evidence for function of the ferredoxin/thioredoxin system in the reductive activation of target enzymes of isolated intact chloroplasts. Arch Biochem Biophys (1989) 1.86
The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus. Nature (1986) 1.84
3' deletions cause aniridia by preventing PAX6 gene expression. Proc Natl Acad Sci U S A (2000) 1.78
WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature (1991) 1.75
Culture and characteristics of hormone-responsive neuroblastoma X glioma hybrid cells. Methods Enzymol (1985) 1.70
Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol (1991) 1.63
Bimane fluorescent labels: labeling of normal human red cells under physiological conditions. Proc Natl Acad Sci U S A (1979) 1.59
Localization of a human Na+,K+-ATPase alpha subunit gene to chromosome 19q12----q13.2 and linkage to the myotonic dystrophy locus. Genomics (1988) 1.55
Isolation and mapping of 62 new RFLP markers on human chromosome 11. Am J Hum Genet (1991) 1.52
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell (1990) 1.52
Positive and negative life changes following sexual assault. J Consult Clin Psychol (2001) 1.46
Thiol labeling with bromobimanes. Methods Enzymol (1987) 1.45
Glutathione. 8. The effects of glutathione disulfide on initiation of protein synthesis. Biochim Biophys Acta (1972) 1.41
Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus. Genetics (2000) 1.37
APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett (1998) 1.32
Formation of disulfides with diamide. Methods Enzymol (1987) 1.28
Genes encoding alpha and beta subunits of Na,K-ATPase are located on three different chromosomes in the mouse. Proc Natl Acad Sci U S A (1987) 1.27
Effect of the thiol-oxidizing agent diamide on the growth of Escherichia coli. J Bacteriol (1970) 1.24
Glutathione. VII. Differentiation among substrates by the thiol-oxidizing agent, diamide. Biochim Biophys Acta (1972) 1.17
Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein. Growth Horm IGF Res (2001) 1.16
Inhibition of protein synthesis by glutathione disulfide in the presence of glutathione. Biochem Biophys Res Commun (1971) 1.15
Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A (1989) 1.14
Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ (1999) 1.11
Bromobimane probes for thiols. Methods Enzymol (1995) 1.11
Sulfur K-edge X-ray absorption spectroscopy of 2Fe-2S ferredoxin: covalency of the oxidized and reduced 2Fe forms and comparison to model complexes. J Am Chem Soc (2001) 1.11
HMG-D is an architecture-specific protein that preferentially binds to DNA containing the dinucleotide TG. EMBO J (1995) 1.10
Decreased glutathione content of human erythrocytes produced by methyl phenylazoformate. Biochem Biophys Res Commun (1965) 1.10
The regeneration of reduced glutathione in normal and glucose-6-phosphate dehydrogenase deficient human red blood cells. Blood (1967) 1.08
Glutathione. II. Chemical aspects of azoester procedure for oxidation to disulfide. Biochim Biophys Acta (1969) 1.07
Phenotypic heterogeneity of CYP1B1: mutations in a patient with Peters' anomaly. J Med Genet (2001) 1.06
Deficient outgrowth of the ureteric bud underlies the renal agenesis phenotype in mice manifesting the limb deformity (ld) mutation. Dev Dyn (1994) 1.05
The eyeless mouse mutation (ey1) removes an alternative start codon from the Rx/rax homeobox gene. Genesis (2001) 1.05
On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Lett (1997) 1.03
Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus. Proc Natl Acad Sci U S A (1991) 1.00
Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab (2000) 0.99
Dynamics of the thiol status of rat spermatozoa during maturation: analysis with the fluorescent labeling agent monobromobimane. Biol Reprod (1989) 0.99
Bimane fluorescent labels. Characterization of the bimane labeling of human hemoglobin. Biochim Biophys Acta (1980) 0.99
A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood (1998) 0.98
Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance. FEBS Lett (1986) 0.97
Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J Pharmacol Exp Ther (1995) 0.97
[Direct and indirect costs of schizophrenia]. Fortschr Neurol Psychiatr (1999) 0.95
cDNA cloning, recombinant expression and characterization of polypetides with exceptional DNA affinity. Nucleic Acids Res (1998) 0.95
3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.94
Mutation at the anophthalmic white locus in Syrian hamsters: haploinsufficiency in the Mitf gene mimics human Waardenburg syndrome type 2. Hum Mol Genet (1998) 0.93
Erythrocyte thiol status regulates band 3 phosphotyrosine level via oxidation/reduction of band 3-associated phosphotyrosine phosphatase. FEBS Lett (1997) 0.93
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol. Psychopharmacology (Berl) (2006) 0.93
The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion. Biochem Biophys Res Commun (1996) 0.92
A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation. Biochemistry (1995) 0.92
Caspase-1 activity is required for neuronal differentiation of PC12 cells: cross-talk between the caspase and calpain systems. Biochim Biophys Acta (2005) 0.92
Glutathione. V. The effects of the thiol-oxidizing agent diamide on initiation and translation in rabbit reticulocytes. Biochim Biophys Acta (1971) 0.92
Glutathione. IV. Intracellular oxidation and membrane injury. Biochim Biophys Acta (1969) 0.92
Cytochemical and ultrastructural changes in rat liver in experimental porphyria. I. Effects of a single injection of allylisopropylacetamide. Lab Invest (1967) 0.91
Sensitivity of hemoglobin thiol groups within red blood cells of rat during oxidation of glutathione. Eur J Biochem (1977) 0.91
The calpain-calpastatin system and protein degradation in fusing myoblasts. Biochim Biophys Acta (1998) 0.91
The recombination activating genes, RAG 1 and RAG 2, are on chromosome 11p in humans and chromosome 2p in mice. Immunogenetics (1992) 0.91
Phosphotyrosine phosphatase associated with band 3 protein in the human erythrocyte membrane. Biochem J (1996) 0.90
Use of spoligotype analysis to detect laboratory cross-contamination. Infect Control Hosp Epidemiol (2000) 0.90
Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine. Psychopharmacology (Berl) (1987) 0.89
Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors. Biochim Biophys Acta (1997) 0.89
Mapping of 262 DNA markers into 24 intervals on human chromosome 11. Am J Hum Genet (1992) 0.89
Glutathione. I. The methyl phenyldiazenecarboxylate (azoester) procedure for intracellular oxidation. Biochim Biophys Acta (1969) 0.89
Does 3,4-dihydroxyphenylalanine play a part in favism? Nature (1967) 0.89
Glutathione. IX. New thiol-oxidizing agents: DIP, DIP+1, DIP+2. Biochem Biophys Res Commun (1974) 0.89
Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. J Pharmacol Exp Ther (1998) 0.89
Glutathione. 3. Biological aspects of the azoester procedure for oxidation within the normal human erythrocyte. Biochim Biophys Acta (1969) 0.88
The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur J Pharmacol (1992) 0.88
TVX 2706--a new phosphodiesterase inhibitor with antiinflammatory action. Biochemical characterization. Agents Actions (1984) 0.87
Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanzmann's thrombasthenia. Br J Haematol (1975) 0.87
Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus. Hum Genet (1992) 0.87
F20C, a new fluorescent membrane probe, moves more slowly in malignant and mitogen-transformed cell membranes than in normal cell membranes. Biochim Biophys Acta (1978) 0.87
Combined HPLC-MS and HPLC-NMR on-line coupling for the separation and determination of lutein and zeaxanthin stereoisomers in spinach and in retina. Anal Chem (2001) 0.86
Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes. Exp Parasitol (1984) 0.86
Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare. Genes Chromosomes Cancer (1991) 0.86
Membrane mobility agents. II. Active promoters of cell fusion. Biochim Biophys Acta (1975) 0.86
Calpain (Ca(2+)-dependent thiol protease) in erythrocytes of young and old individuals. Proc Natl Acad Sci U S A (1994) 0.86
Membrane thiol-disulfide status in glucose-6-phosphate dehydrogenase deficient red cells. Relationship to cellular glutathione. Biochim Biophys Acta (1982) 0.85
Fluorescent localization of thiols and disulfides in marsupial spermatozoa by bromobimane labelling. Mol Reprod Dev (1994) 0.85
Band 3 protein degradation by calpain is enhanced in erythrocytes of old people. Biochem J (1991) 0.85
Role of iron in transferrin-dependent lymphocyte mitogenesis in serum-free medium. Exp Cell Res (1982) 0.85
Membrane-mobility agent-promoted fusion of erythrocytes: fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins. Proc Natl Acad Sci U S A (1983) 0.85
Thiol-disulfide status of human sperm proteins. J Reprod Fertil (1994) 0.85
Membrane mobility agent alters the consequences of lectin-cell interaction in a malignant cell membrane. Biochim Biophys Acta (1975) 0.85